Skip to main content
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.010
+0.050 (1.26%)
At close: Nov 13, 2026, 4:00 PM EST
3.994
-0.016 (-0.41%)
After-hours: Nov 13, 2026, 5:06 PM EST

Artiva Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
198105245---
Market Cap Growth
126.05%-56.99%----
Enterprise Value
-112-6113---
Last Close Price
3.964.2910.08---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--975.44---
PB Ratio
0.610.961.31---
P/TBV Ratio
0.620.961.31---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--450.89---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.100.080.310.260.01
Net Debt / Equity Ratio
-0.97-0.88-0.92-1.10-1.10-1.25
Net Debt / EBITDA Ratio
3.031.112.642.111.423.00
Net Debt / FCF Ratio
3.581.223.071.191.459.35
Asset Turnover
--0.000.280.030.02
Quick Ratio
19.558.3115.226.454.028.36
Current Ratio
19.888.6115.406.534.098.41
Return on Equity (ROE)
-43.61%-56.55%-54.24%-44.15%-57.84%-99.72%
Return on Assets (ROA)
-26.74%-32.97%-26.72%-16.10%-24.68%-33.43%
Return on Capital Employed (ROCE)
-32.20%-76.20%-34.10%-33.00%-55.70%-35.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-69.83%-79.65%-26.70%---
FCF Yield
-43.69%-75.35%-22.74%---
Buyback Yield / Dilution
-43.62%-117.11%-1302.54%-4.70%-11.80%-8.60%
SEC Filings: 10-K · 10-Q